26 October 2022 | News
Report to guide global effort to address once overlooked group
image credit- shutterstock
At the top of the list are fungal species threatening healthcare that are already or have increasing resistance to antifungal agents, such as Aspergillus fumigatus and Candida Auris.
During the COVID-19 pandemic, the incidence of at least three deadly fungal pathogens increased – comorbid aspergillosis, mucormycosis and candidemia. Evidence is also starting to suggest that the incidence and geographic range of fungal diseases are increasing worldwide due to climate change.
There are only four classes of anti-fungal medicines currently available, with only a few drugs currently undergoing clinical trials. In addition, methods to diagnose fungal infection or detect drug resistance are not widely available globally.